Announcing the new Bone Marrow Transplantation impact factor: 3.400*
6/21 in Transplantation
20/62 in Hematology
39/121 in Immunology
54/141 in Oncology
*2008 Journal Citation Reports (Thomson Reuters, 2009)
Free online issue
Volume 43, No 12
June (2) 2009
ISSN: 0268-3369
EISSN: 1476-5365
2008 impact factor 3.400*
6/21 Transplantation
20/62 Hematology
39/121 Immunology
54/141 Oncology
Editor:
J M Goldman, UK
*2008 Journal Citation Reports (Thomson Reuters, 2009)
FEATURED ARTICLES
ORIGINAL ARTICLE
Rescue From Failed Growth Factor and/or Chemotherapy HSC Mobilization With G-CSF and Plerixafor (AMD3100): an Institutional Experience FREEREVIEW
Optimal Use of G-CSF administration after hematopoietic stem cell transplantationORIGINAL ARTICLE
Pegfilgrastim for peripheral CD34+ mobilisation in patients with solid tumoursORIGINAL ARTICLE
Intra-bone marrow injection to enhance engraftment after myeloablative of umbilical cord blood transplantation with 2 partially HLA-matched unitsORIGINAL ARTICLE
Low bone mineral density is associated with insulin resistance in bone marrow transplant subjectsNews
More free articles
Bone Marrow Transplantation articles are now free online 12 months after print publication. Browse through our past papers in the archive
Special Issues
Special Issue on the role of allografting in adults with acute leukaemia
Guest edited by David Marks, this special issue is a comprehensive description of transplant options for adults with acute leukaemia. Written by acknowledged world experts, it includes a comparison of different stem cell sources, and looks at reduced intensity allografting, cellular immunotherapy and post transplant relapse.
Special Issue on Pediatric Blood & Marrow Transplantation
Guest edited by Mitchell S. Cairo and Helen Heslop, this special issue is the first of its kind. It is a detailed review of blood and marrow transplantation for most common childhood malignant and non-malignant diseases and will serve as a benchmark for similar focuses in future.
Guest edited by Ray Powles, Kenneth Anderson, Jean Luc Harrousseau and Bhawna Sirohi, this special issue comes at a crucial time as it follows three new targeted therapies recently approved for myeloma. It gives guidance on how the sequence of treatments and supportive therapy can be combined to optimize the patient's treatment pathway and produce prolonged normal symptom-free survival. It is a model for other Cancers.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals

